Skip to main content
. 2022 Oct 19;21:15330338221133640. doi: 10.1177/15330338221133640

Figure 2.

Figure 2.

Kaplan–Meier curves showing PFS of comparison of TACE plus lenvatinib and PD-1 inhibitor with TACE plus lenvatinib (A), and TACE plus lenvatinib and PD-1 inhibitor with TACE plus sorafenib (B).

Abbreviations: CI, confidence interval; HR, hazard ratio; PFS, progression-free survival; PD-1, programmed death 1; TACE, transarterial chemoembolization.